Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

被引：180

作者：

Petrov, Kimberly G. ^{[1
]}

Zhang, Yue-Mei ^{[1
]}

Carter, Malcolm ^{[1
]}

Cockerill, G. Stuart ^{[1
]}

Dickerson, Scott ^{[1
]}

Gauthier, Cassandra A. ^{[1
]}

Guo, Yu ^{[1
]}

Mook, Robert A., Jr. ^{[1
]}

Rusnak, David W. ^{[1
]}

Walker, Ann L. ^{[1
]}

Wood, Edgar R. ^{[1
]}

Lackey, Karen E. ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 17期

关键词：

ErbB-1 tyrosine kinase inhibitors; ErbB-2 tyrosine kinase inhibitors; EGFR kinase inhibitors; quinazoline; lapatinib;

D O I：

10.1016/j.bmcl.2006.05.090

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Synthetic modifications on a 6-furanylquinazoline scaffold to optimize the dual ErbB-1/ErbB-2 tyrosine kinase inhibition afforded consistent SAR whereby a 4-(3-fluorobenzyloxy)-3-haloanilino provided the best enzyme potency and cellular selectivity. Changes made to the 6-furanyl group had little impact on the enzyme activity, but appeared to dramatically affect the cellular efficacy. The discovery of lapatinib emerged from this work. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：4686 / 4691

页数：6

共 50 条

[1] Expression of ErbB-1 and ErbB-2 in meningioma
Wickremesekera, Agadha
Hovens, Christopher M.
Kaye, Andrew H.
JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (09) : 1155 - 1158
[2] Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2 - Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity
Fernandes, AM
Hamburger, AW
Gerwin, BI
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (06) : 701 - 709
[3] 肺癌erbB-1、erbB-2基因扩增研究
周海涛
孙开来
张学
金春莲
杨志山
胡永校
赵惠儒
中国医科大学学报, 1993, (05) : 336 - 339
[4] The future of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: Targeting multiple receptors
Slamon, DJ
ONCOLOGIST, 2004, 9 : 1 - 3
[5] Gene copy numbers and expression of ErbB-1 and ErbB-2 in breast cancer
不详
EJC SUPPLEMENTS, 2006, 4 (02): : 139 - 139
[6] Interaction between ErbB-1 and ErbB-2 transmembrane domains in bilayer membranes
Sharpe, S
Barber, KR
Grant, CWM
FEBS LETTERS, 2002, 519 (1-3) : 103 - 107
[7] Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium
Brys, Magdalena
Semczuk, Andrzej
Rechberger, Tomasz
Krajewska, Wanda M.
ONCOLOGY REPORTS, 2007, 18 (01) : 261 - 265
[8] Lapatinib, a dual ErbB-1/ErbB-2 kinase inhibitor, in the treatment of HER2-overexpressing locally advanced and metastatic breast cancer
不详
CLINICAL BREAST CANCER, 2006, 7 (03) : 224 - 227
[9] Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms
Brys, M
Stawinska, M
Foksinski, M
Barecki, A
Zydek, C
Miekos, E
Krajewska, WM
ONCOLOGY REPORTS, 2004, 11 (01) : 219 - 224
[10] ErbB-1 and ErbB-2 homologues are expressed in cancer of dog and recognised by cetuximab and trastuzumab antibodies
Singer, J.
Weichselbaumer, M.
Stockner, T.
Mechtcheriakova, D.
Sobanov, Y.
Wrba, F.
Horvat, R.
Thalhammer, J.
Willmann, M.
Jensen-Jarolim, E.
ALLERGY, 2011, 66 : 449 - 449

← 1 2 3 4 5 →